Novogene Tianjin to offer end-to-end sequencing through interpretation and reporting by integrating LifeMap’s leading TGex Clinical NGS tertiary analysis platform with their sequencing and bioinformatics services in China Partnership to expand LifeMap’s access to the Chinese Market ALAMEDA, Calif. – LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE) announced today that Tianjin […]
MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, today announce a major strategic alliance to create turnkey research solutions for the pharmaceutical and health sectors. The first-of-a-kind partnership brings together BC Platform’s global network of biobanks and MedEngine’s expertise […]
MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, today announce a major strategic alliance to create turnkey research solutions for the pharmaceutical and health sectors. The first-of-a-kind partnership brings together BC Platform’s global network of biobanks and MedEngine’s expertise […]
Consortium leverages DNAnexus cloud-based platform to scale genome assembly and improve quality for the maize population MOUNTAIN VIEW, Calif.–DNAnexus, the global leader in genome informatics and data management, today announced details of its collaboration with Dawe lab from University of Georgia, Hufford lab from Iowa State University, and Ware lab from Cold Spring Harbor Laboratory […]
ANN ARBOR, MI Investment Drives Commercial Expansion into Pharma and Clinical Diagnostic Labs Genomenon® announced that it has completed a $2.5M equity financing round. The financing will expand the company’s commercial reach with clinical diagnostic labs, biotech, and pharmaceutical companies. Genomenon connects patient DNA with the evidence in scientific literature to help doctors provide faster […]
Enhancing QIAGEN’s industry-leading position with access to MarkerMine™ database and real-world evidence insights that provide insights for targeted therapy options Redwood City, California, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer […]
San Francisco, Jan. 4, 2019: SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data- Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, […]
SOUTH SAN FRANCISCO, Calif.–Verily, an Alphabet company, today announced a $1 billion investment round, led by Silver Lake, as it advances plans on business strategies that are additive and complementary to its current life sciences portfolio. Other new investors in the round include Ontario Teachers’ Pension Plan and other global investment management firms. The capital […]
BOSTON — IOMICS announced the release of its first cloud-deployed analytics service, ASPEN, based on the award-winning FUSION Analytics Platform. ASPEN allows every bench scientist to automatically mine and model complex multiscale datasets to identify molecular signatures of pathogenic processes and disease progression critical to drug development, companion diagnostics, and personalized patient profiling. “The pace and complexity of biological research […]
Ecosystem Encourages Integration and Access to Innovative Capabilities Across the Healthcare and Life Sciences Space BOSTON Vyasa Analytics, a provider of scalable, deep-learning software and analytics for life sciences and healthcare organizations, today announced they have joined Accenture’s partner ecosystem, designed to help independent software vendors (ISVs) and life science companies work more effectively to accelerate […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
